Parenteral Medicines Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 547.55 Cr
- Satisfied Charges ₹ 14.48 Cr
- Revenue Growth %
- Profit Growth 3.48%
- Ebitda 3.91%
- Net Worth -36.34%
- Total Assets -8.29%
About Parenteral Medicines
Parenteral Medicines Limited (PML) is a Public Limited Indian Non-Government Company incorporated in India on 01 December 1995 and has a history of 29 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹547.55 Cr. The company has closed loans amounting to ₹14.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aruna Gupta, Alpana Gupta, and Shashi Garg serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1995PLC094929
-
Company No.
094929
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 Dec 1995
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Parenteral Medicines?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aruna Gupta
|
Director | 09-Feb-2016 | Current |
|
Alpana Gupta
|
Director | 09-Feb-2016 | Current |
|
Shashi Garg
|
Director | 09-Feb-2016 | Current |
Financial Performance of Parenteral Medicines.
Parenteral Medicines Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parenteral Medicines?
In 2021, Parenteral Medicines had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Chiron Metco Private LimitedAruna Gupta is a mutual person
-
Fastrack Aviation Private Limited
Aruna Gupta is a mutual person
-
Vino Infratech Private Limited
Aruna Gupta is a mutual person
-
Rajratan Exports Private Limited
Aruna Gupta, Alpana Gupta and 1 more are mutual person
Charges (Loans)
₹5,475.50 M
₹144.80 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 547.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2012 | State Bank Of India | ₹547.55 Cr | Open |
| 31 Mar 2015 | Lakshmi Vilas Bank Limited | ₹14.00 Cr | Satisfied |
| 22 Dec 2005 | State Bank Of India | ₹4.80 M | Satisfied |
How Many Employees Work at Parenteral Medicines?
Unlock and access historical data on people associated with Parenteral Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parenteral Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parenteral Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
